不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel：ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
tisagenlecleucel 治疗后孤立性口腔 CAR 阳性 T 细胞淋巴瘤
英文原题：Isolated oral CAR(+) T cell lymphoma after tisagenlecleucel.
查看英文原题
Isolated oral CAR(+) T cell lymphoma after tisagenlecleucel.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Leick MB、Maus MV
- 第一作者单位
- Cellular Immunotherapy Program, Massachusetts General Brigham Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.United States
- 通讯作者单位
- Cellular Immunotherapy Program, Massachusetts General Brigham Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mvmaus@mgh.harvard.edu.United States
- 期刊
- Molecular therapy : the journal of the American Society of Gene Therapy2025 Dec 3
- 原文标识
- PubMed 41240907 · DOI 10.1016/j.ymthe.2025.10.059